Cited by

• Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?

  Chouchene S, Dabboubi R, Raddaoui H, Abroug H, Ben Hamda K, Hadj Fredj S, Abderrazak F, Gaaloul M, Rezek M, Neffeti F, Hellara I, Sassi M, Khefacha L, Sriha A, Nouira S, Najjar MF, Maatouk F, Messaoud T, Hassine M. Chouchene S, et al. Eur J Clin Pharmacol. 2018 Dec;74(12):1567-1574. doi: 10.1007/s00228-018-2530-5. Epub 2018 Aug 3. Eur J Clin Pharmacol. 2018. PMID: 30073432
• The frequencies of CYP2C19*2, *3, and *17 alleles and their impact on the clinical efficacy of doubled maintenance dose of clopidogrel in Syrian patients with coronary artery disease.

  Haj Saleh N, A Youssef L. Haj Saleh N, et al. BMC Cardiovasc Disord. 2025 Apr 28;25(1):330. doi: 10.1186/s12872-025-04768-8. BMC Cardiovasc Disord. 2025. PMID: 40295977 Free PMC article.
• Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.

  Jmel H, Romdhane L, Ben Halima Y, Hechmi M, Naouali C, Dallali H, Hamdi Y, Shan J, Abid A, Jamoussi H, Trabelsi S, Chouchane L, Luiselli D, Abdelhak S, Kefi R. Jmel H, et al. PLoS One. 2018 Apr 13;13(4):e0194842. doi: 10.1371/journal.pone.0194842. eCollection 2018. PLoS One. 2018. PMID: 29652911 Free PMC article.
• Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.

  Ammar H, Chadli Z, Mhalla A, Khouadja S, Hannachi I, Alshaikheid M, Slama A, Ben Fredj N, Ben Fadhel N, Ben Romdhane H, Chaabane A, Boughattas NA, Gaha L, Zarrouk L, Aouam K. Ammar H, et al. Pharmacogenomics J. 2021 Oct;21(5):551-558. doi: 10.1038/s41397-021-00231-x. Epub 2021 Mar 17. Pharmacogenomics J. 2021. PMID: 33731885
• Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population.

  Alqasrawi MN, Al-Mahayri ZN, Alblooshi H, Alsafar H, Ali BR. Alqasrawi MN, et al. Curr Vasc Pharmacol. 2024;22(3):218-229. doi: 10.2174/0115701611283841231227064343. Curr Vasc Pharmacol. 2024. PMID: 38284696